baber/WOPTO huggingface dataset:
Patent AU-2004239011-A1 (AU)
Title: Pneumatically or electromotively operable disc brake
Inventor: KNOOP DIETMAR
IPC: F16D65/14
Filed: 2004-05-18
Abstract: A pneumatically or electromotively operable disc brake for a commercial vehicle, including a brake caliper, which straddles a brake disc, and at least one brake application device for tensioning the disc brake. The side of the brake application device that faces the brake disc is provided with at least one pressing piece, which is sealed with regard to the brake caliper by deformable metal bellows made of a sheet metal material, which are connected to the brake caliper and to the pressing piece.
Patent AU-2004266484-A1 (AU)
Title: Polymeric drug release system for medical devices
Inventor: LOTT MARTYN
IPC: A61F2/06
Filed: 2004-08-18
Abstract: A coating composition comprising a mixture of a poly(vinylacetal-co-vinylalcohol-co-vinylacetate) and a poly(vinylpyrrolidone-co-vinylacetate) allows a medical device to be coated with a first layer containing a first bioactive material (such as rapamycin) and a second layer containing a second bioactive material (such as dexamethasone) for release in vivo at different release rates.
Patent WO-2005068469-A1 (WO)
Title: Complexes metalliques polynucleaires partiellement encapsules par des cucurbit[7-12]uriles
Inventor: WHEATE NIAL JOSEPH
IPC: A61K31/4188
Filed: 2005-01-14
Abstract: L'invention concerne des complexes métalliques polynucléaires partiellement encapsulés par un ou plusieurs cucurbit[7-12]urile(s) ou analogues de celui/ceux-ci. L'invention concerne également des méthodes permettant de traiter le cancer par administration d'un complexe métallique polynucléaire possédant une activité anti-tumorale partiellement encapsulé par un ou plusieurs cucurbit[7-12]urile(s) ou analogues de celui/ceux-ci.
Patent WO-2006012688-A1 (WO)
Title: A method of treating cancer comprising a vegf-b antagonist
Inventor: NASH ANDREW
Filed: 2005-08-02
Abstract: The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.
Patent AU-2005201597-A1 (AU)
Title: Method and apparatus for dynamic group address creation
Inventor: BUCKLEY ADRIAN
IPC: H04M3/00
Filed: 2005-04-15
Abstract: Method and apparatus for creating and maintaining dynamic group addresses for facilitating Push-to-Talk over Cellular (PoC) group communication sessions among mobile stations (302) in a communications network are disclosed. In one embodiment the method comprises receiving at least one rule defining a member of the dynamic group in association with a group address; and populating the dynamic group with members from said mobile stations (302) determined in accordance with the at least one rule. Rules may be defined with reference to presence and/or location information available for the mobile stations (302). Such information may be published on behalf of the stations to one or more servers (310) adapted to identify mobile stations matching the rules. The method may comprise subscribing to the servers (304,308,310) to obtain the matching mobile stations (302) with which to populate dynamic group addresses. <IMAGE>
Patent AU-2005201888-A1 (AU)
Title: Improvements in or relating to collets for tube couplings
Inventor: GUEST TIMOTHY STEPHEN
IPC: B29C48/00
Filed: 2005-05-04
Abstract: A collet for locking a tube in a tube coupling body is moulded in plastics and comprises an annular collar (11) having a plurality of arms (13) extending from the collar generally parallel to the collar axis. Each arm (13) has a head (15) at its distal end spaced from the collar for engaging between a tube and coupling body to lock the tube in the coupling body. Different materials are used for the heads (15) of the collet and the rest of the collet whereby the heads (15) are stronger and relatively rigid whereas the rest of the collet is relatively flexible. <IMAGE>
Patent AU-2005209701-A1 (AU)
Title: Information process device
Inventor: TANIMURA TATSUHIKO
IPC: A63F11/00
Filed: 2005-09-13
Abstract: In the information process device 1, only when it is determined that the password rewritten in the change password memory area 14a of the backup RAM 14 and the password rewritten in the change password memory area 31a of the second flash memory 31 coincide with each other (S202: YES), the menu display of the liquid crystal display 21 is conducted (S107) and it is permitted to start execution of the application program (S123) based on that the menu M2 of "2. start of game" is selected in the menu display. Further, based on that the menu M1 of "1. set of password" is selected in the menu display (S109: 1), it is permitted input of the change password by touching each of the areas 22c to 22n of the transparent touch panel 22 (S112).
Patent AU-2005280698-A1 (AU)
Title: Method for producing sour milk products, method for treating milk therefor, sour milk production line, device for treating milk for said line.
Inventor: SOTNIKOV VALERY ALEXANDROVICH
IPC: A23C9/152
Filed: 2005-08-08
Abstract: The present inventions belong to the milk industry and can be used for producing pasteurized whole or restored milk and sour milk products on their basis, with a long-term storage time and improved organoleptic characteristics. The inventions provide more careful sterilization of milk and elimination of secondary contamination of products during all production stages thereof. The inventions consist in the method for producing sour milk products consisting in carrying out a milk treatment process and subsequent operations in the presence of soluble in milk derivative of polyphosphoric acid of general formula <?in-line-formulae description="In-line Formulae" end="lead"?>HO-[PO<SUB>3</SUB>X]<SUB>n</SUB>-PO<SUB>3</SUB>X<SUB>2</SUB>, <?in-line-formulae description="In-line Formulae" end="tail"?> wherein X represents sodium, or potassium, or calcium, or magnesium, or hydrogen or ammonium ions, and 30>=n>=1 at a quantitative value thereof ranging from 0.4 to 0.7 g/l; the milk treatment is carried out with double pasteurization, bottling and packing are associated with hermetic sealing at a temperature of 68-72° C. up to the second pasteurization, ferment is applied into hermetically sealed milk at ultraviolet irradiation of applying ferment area and is followed by the final hermetic sealing of a package afterwards. The invention also consists in the method of milk treating when after the first pasteurization the milk is kept at a temperature 68-72° C. for not less than 15 minutes for a drinking milk, and not less than 5 minutes for sour milk products, bottling with hermetic sealing is carried out after this keeping at the said temperature, then hermetically sealed milk is cooled down to a temperature of 12-37° C. and kept at this temperature for not less than 30 minutes, the second pasteurization is carried out after the said keeping by heating the milk to a temperature 68-72° C. at a heating rate equal to or greater than 10° C./sec. The inventions also consist in the structural design of the line for realization of the method of production of sour milk products, in the structural design of the device for milk treating for realization of the method of milk treating.
Patent AU-2005337873-A1 (AU)
Title: Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
Inventor: SUKHATME VIKAS P
IPC: G01N33/53
Filed: 2005-12-15
Abstract: Disclosed herein are methods for diagnosing or treating pregnancy related hypertensive disorders that include the use of a polypeptide or a nucleic acid encoding a polypeptide selected from the following: follistatin related protein, interleukin 8, inhibin A, VEGF-C, angiogenin, beta fertilin, hypothetical protein, leukocyte associated Ig-like receptor secreted protein, erythroid differentiation protein, adipogenesis inhibitory factor, corticotropin releasing factor binding protein, alpha-1 anti-chymotrypsin, insulin-like growth factor binding protein-5, CD33L, cytokine receptor like factor 1, platelet derived endothelial growth factor, lysyl hydroxylase isoform 2, stanniocalcin precursor, secreted frizzled related protein, galectin-3, alpha defensin, ADAM-TS3, cholecystokinin precursor, interferon stimulated T-cell alpha chemoattractant precursor, azurocidin, sperminine oxidase, UDP glycosyltransferase 2 family polypeptide B28, neurotrophic tyrosine kinase receptor 2, neutral endopeptidase, CDC28 protein kinase regulatory subunit 2, beta glucosidase, lanosterol synthase, calcium/calmodulin-dependent serine protein kinase, estrogen receptor-alternatively spliced transcript H, chemokine (CX3C motif) receptor 1, tyrosinase-related protein 1, hydoxy-delta-5-steroid dehyrogenase, dihydropyramidinase-like-4, and cytochrome P450-family 11.
Patent WO-2007016743-A1 (WO)
Title: Systemes optiques a lentilles
Inventor: FRAZIER JAMES ALBERT
IPC: G02B13/24
Filed: 2006-08-10
Abstract: L’invention concerne des systèmes optiques à grand angulaire, à champ profond et à focalisation rapprochée (1100, 1200, 1300, 1400). Selon un aspect, le système optique (1100) comprend un module à lentille négative (1110) et une lentille relais (1160). Le module à lentille négative (1100) reçoit un rayonnement émanant d’un objet dans l’espace. La lentille relais (160) est couplée au module à lentille négative (1110). Le module à lentille négative (1110) et la lentille relais (1160) sont alignés sur un axe optique dans cet ordre. Le module à lentille négative (1110) forme une première image sur la lentille relais (1160) pour former une image finale au niveau d’un plan d’image finale situé à une certaine distance de la lentille relais (1160). La lentille relais (1160) peut comprendre une lentille à focale variable ou des composants de lentille à focale variable qui peuvent être mobiles.
Patent AU-2006203640-A1 (AU)
Title: Therapeutic use of a recombinant erythropoietin for prevention or treatment of chronic heart failure and associated fatigue or pain
Inventor: THOMPSON LAWRENCE H
IPC: A61K33/24
Filed: 2006-08-17
Abstract: The invention discloses several novel therapeutic properties and methods of treatment using the recombinant erythropoietin prepared by expression from the Apa I restriction fragment of human genomic erythropoietin DNA transformed into baby hamster kidney cells (BHK) according to U.S. Patent No. 5,688,697 to Powell. This recombinant erythropoietin designated herein as Epoetin Omega is shown to possess several unexpected and superior qualities over other recombinant erythropoieteins such as those designated Epoetin Alfa and Beta which are prepared from genomic or cDNA expressed in Chinese Hamster Ovary (CHO) according to U.S. Patent Nos. 4,703,008 and 5,955,422 to Lin. The superior properties of Epoetin Omega include, but are not limited to, a much higher potency, a much more rapid response (i.e. no latency), longer effective serum levels, much lower antigenicity in human subjects, therapeutic activity in subjects non-responsive to the other epoetins, fewer adverse side effects such as incidents of thrombosis, reduced nausea, reduced pain at the site of injection, reduction in body pain, and most significantly, the absence of, or reduced risk of, increased blood pressure or hypertension. These novel properties provide for novel therapeutic methods including, treatment of anemia and treatment of conditions other than anemia such as fatigue or vascular pain, treatment in patients adversely effected by hypertension such as patients with heart conditions or at increased risk of thrombosis, treatment in oncology settings with and without chemotherapy or radiation therapy, and treatment with novel dosing regiments that include much lower doses and lower administration frequencies of as few as once per week or less.
Patent AU-2006251208-A1 (AU)
Title: Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
Inventor: PORSTMANN FRANK RALF
IPC: C07F9/09
Filed: 2006-05-22
Abstract: The present invention relates to a process for isolating (αS,βR)-6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol from a mixture of stereoisomeric forms of 6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol by optical resolution with chiral 4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin 4-oxide or a derivative thereof, in particular (11bR)-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin 4-oxide, as resolution agent.
Patent AU-2006263415-A1 (AU)
Title: Oligomeric amidoamines or amidoquats for fabric or hair treatment compositions
Inventor: LAITEM LEOPLD
IPC: A61Q5/12
Filed: 2006-06-29
Abstract: Provided are oligomeric amidoamines, an oligomeric amidoamine salt of the oligomeric amidoamine, and/or an oligomeric amidoquat of the oligomeric amidoamine. These materials can be used as fabric softeners in fabric softener compositions or as a hair treatment in hair treatment compositions.
Patent AU-2006302729-A1 (AU)
Title: Multicomponent nucleic acid enzymes and methods for their use
Inventor: DOAN TRAM BICH
IPC: C12Q1/68
Filed: 2006-10-06
Abstract: The present invention relates to Multicomponent Nucleic Acid Enzymes (MNAzymes) and methods for their use. MNAzymes comprise two or more oligonucleotide components which self-assemble in the presence of one or more MNAzyme assembly facilitator molecules to form a catalytically active structure. Compositions for making MNAzymes, and collections of MNAzymes are provided. Also provided are methods for using MNAzymes for the detection, identification and/or quantification of one or more targets. The methods can be practiced in solution-based assays or in assays where one or more reaction components are attached to a support structure. The methods allow for multiplexing the MNAzyme detection to detect multiple targets in a single reaction. Also provided are kits for making the compositions, and for practicing the methods provided herein.
Patent AU-2006326497-A1 (AU)
Title: Vibratory separator
Inventor: BROWNE NEAL
IPC: B01D19/00
Filed: 2006-12-13
Abstract: An apparatus for separating solids from a drilling fluid that includes a basket having two opposed spaced-apart side walls having first ends and second ends, the first ends spaced apart by an end wall connected to each of the side walls, the basket further including a bottom wall through which a fluid outlet passage is defined, a plurality of screening surfaces having a front edge and a back edge and positioned within the basket between the side walls with each screening surface spaced apart vertically from adjacent screening surfaces and the back edge spaced apart from the end wall of the basket, wherein the back edge of each screening surface is lower than the front edge of the corresponding screening surface, a plurality of weirs, each weir retained along the back edge of a corresponding screening surface and spaced apart from the end wall to define a fluid passage between each weir and the end wall, wherein each weir has a top edge extending to a weir height above the back edge of the corresponding screening surface and the top edge is lower than the front edge of the corresponding screening surface, at least one flow director catching unseparated drilling fluid in the fluid passage and directing the unseparated drilling fluid onto a lower screen, and wherein fluid in the fluid passage between the lowermost screen and the end wall is directed to a spillover fluid outlet is disclosed.
Patent WO-2007137322-A1 (WO)
Inventor: DURSO ROBERTO FRANCESCO
IPC: A61H7/00
Filed: 2007-02-22
Abstract: A skin treatment tool (32) having a handgrip (32) comprising a body (34) having at least one convexly curved side (37) and a skin contacting element set within the body (34) and having an exposed edge (33) which is convexly curved along its length and which is located outwardly of the convexly curved side (37) of the body (34) and extends therealong, the edge (33) comprising a dull and blunt non-invasive edge.
Patent WO-2008061294-A1 (WO)
Title: Structures et procédé de couverture de décharges
Inventor: LACEY GRANT LLOYD
IPC: B09B1/00
Filed: 2007-11-16
Abstract: L'invention concerne une structure fermée modulaire semblable à un toit, munie de fixations appropriées pour sa manipulation par des engins de levage en vue d'être placée sur un site de décharge, ainsi que d'un prolongement en bande de périmètre s'appuyant sur, ou recouvrant, un module voisin sur le site. La structure modulaire est munie d'un évent pour permettre la ventilation de la décharge et l'évent contient un filtre afin d'extraire les gaz nocifs et les odeurs. La structure contient également un système de pulvérisation de liquide destiné à pulvériser de l'insecticide et du déodorant sur la décharge, et un système anti-incendie activé automatiquement lorsque de la fumée est détectée.
Patent AU-2007306674-A1 (AU)
Title: Light
Inventor: VONHOFF JURGEN
IPC: F21V31/00
Filed: 2007-10-08
Abstract: The invention relates to a light (1) especially a wall or ceiling light protected from spray water and used to receive at least one long gas discharge lamp (5), said light comprising a closed housing formed by an at least transparent base part (3) which can be mounted in a fixed location and holds electrical devices, and an at least transparent coupling part (2). The base part (3) and the coupling part (2) are injection-molded from the same charges of thermoplastic material in a common mold which is essentially symmetrical in terms of the injection process, and overlap along peripheral edges on both sides, one edge being an insertion edge (10) and the other edge being embodied as a U-shaped receiving element (9) for receiving the insertion edge (10). According to the invention, taking into consideration the characteristic features of the transparent or translucent plastic material and the requirements of large-scale production, the light is designed in such a way that the U-shaped receiving element (9) comprises a seal (14) consisting of an elastomer foam forming a smooth outer skin, and the inner wall (15) of the light is provided with a surface structure improving the adhesion, for receiving the seal (14).
Patent WO-2008104031-A1 (WO)
Title: Plate-forme de manutention de matériau, composants et procédés de production de celle-ci
Inventor: WATSON BRUCE
IPC: B29C48/91
Filed: 2008-02-29
Abstract: La présente invention concerne un procédé de fabrication d'un matériau en feuille au moyen de fibre de verre, comme des fibres de verre (802, 803), un revêtement de fibres de verre (801) et/ou une toile/bande de fibres de verre (601), et un polymère, comme du polypropylène. La fibre de verre est revêtue d'un polymère liquide et formée sous forme de matériau en feuille (800), de préférence par des cylindres compresseurs (808, 810). Le produit de matériau est formé, par cintrage/pliage, dans des formes souhaitées, comme des sections de rectangulaires pour former des sections de plate-forme de support/palette. Les sections formées peuvent être fixées ensemble, par exemple au moyen d'éléments allongés traversant une série d'ouvertures alignées entre des sections adjacentes. Les éléments allongés peuvent être fixés à chaud sur les sections. Des éléments rapportés peuvent être utilisés dans les extrémités des sections pour conférer une rigidité et une résistance supplémentaires. Ainsi, une plate-forme de support/palette composite peut être fabriquée sur une chaîne de production.
Patent WO-2008124872-A1 (WO)
Title: Population de cellules souches neurales latentes
Inventor: WALKER TARA LOUISE
IPC: A61K35/12
Filed: 2008-04-10
Abstract: La présente invention porte sur une population de cellules souches neurales latentes qui est capable d'activation par dépolarisation de membrane d'une population de cellules neurales, isolement et culture de celle-ci, et sur ses utilisations.
Patent AU-2008255383-A1 (AU)
Title: Method for manufacturing a recombinant polyclonal protein
Inventor: WEILGUNY DIETMAR
IPC: C12N15/10
Filed: 2008-05-21
Abstract: The invention relates to a method for manufacturing a recombinant polyclonal protein composition, in particular a recombinant polyclonal antibody composition. The method comprises obtaining a collection of cells transfected with a collection of variant nucleic acid sequences, wherein each cell in the collection is transfected with and capable of expressing one member of the collection, which encodes a distinct member of a polyclonal protein. The cells are cultured under suitable conditions for expression of the polyclonal protein, which is obtained from the cells or culture supernatant. The nucleic acid sequence is introduced into the cells by transfection with a collection of vectors. The present method is suitable for manufacturing recombinant polyclonal antibodies for therapeutic uses.
Patent WO-2009094697-A1 (WO)
Inventor: TOWNSEND RICHARD
IPC: B25B27/00
Filed: 2009-01-29
Abstract: There is provided a tool for manipulating an article comprising; an operative portion having a convex surface defined by a first curved segment extending substantially from a first end. The first curve segment is defined by a radius greater than at least one further subsequent curved segment used to define the convex surface. The operative portion further comprises a concave surface that is opposite said convex surface. During use, one of said convex or concave surfaces is enageable with an article and the other of said convex or concave surfaces is engageable with a work-piece so the convex and concave surfaces become cooperable so that a fulcrum point is established between the work piece and the other surface.
Patent WO-2010043000-A1 (WO)
Title: Modulateurs des récepteurs s1p et leur utilisation
Inventor: GILL GURMIT S
IPC: C07D311/22
Filed: 2009-10-19
Abstract: Cette invention concerne de nouveaux composés présentant une activité modulatrice des récepteurs S1P. L’invention concerne également un agent pharmaceutique comprenant au moins un composé de l’invention utilisé dans le traitement de maladies et/ou d’affections causées par ou associées avec une activité modulatrice ou une expression des récepteurs S1P inappropriées, par exemple une réponse auto-immune. L’invention concerne par ailleurs l’utilisation d’un agent pharmaceutique comprenant au moins un composé de l’invention dans la fabrication d’un médicament destiné au traitement de maladies et/ou d’affections causées par ou associées avec une activité modulatrice ou une expression des récepteurs S1P inappropriées telle qu’une réponse auto-immune.
Patent AU-2009331894-A1 (AU)
Title: Method for cyclically operating coke oven banks from "heat recovery" coke oven chambers
Inventor: RONALD KIM
IPC: C10B15/02
Filed: 2009-12-18
Abstract: The invention relates to a method for cyclically operating a coke oven device, wherein said device comprises an even number of coke oven banks, each in turn comprising an even number of coke oven chambers. Boiler devices are connected downstream of the coke oven banks, driving turbines using the hot exhaust gases from the coke oven banks. Energy is obtained in this manner. The coke oven chambers are cleared and filled in a precisely defined cycle, so that the production of hot exhaust gas can be homogenized over time.